Gene Symbol | Gene ID | Gene Info |
---|---|---|
VSX1
|
ENSG00000100987.10 | visual system homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_25071203_25071354 | VSX1 | 8282 | 0.211093 | -0.82 | 6.9e-03 | Click! |
chr20_25057715_25057866 | VSX1 | 4977 | 0.223332 | -0.79 | 1.1e-02 | Click! |
chr20_25071716_25071887 | VSX1 | 8805 | 0.209608 | -0.74 | 2.1e-02 | Click! |
chr20_25064708_25064859 | VSX1 | 1787 | 0.376087 | -0.68 | 4.5e-02 | Click! |
chr20_25058000_25058151 | VSX1 | 4692 | 0.227015 | -0.64 | 6.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_33934050_33934291 | 0.77 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
20334 |
0.2 |
chr12_89453867_89454269 | 0.67 |
ENSG00000238302 |
. |
221994 |
0.02 |
chr14_101308246_101309004 | 0.63 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr4_140958813_140959347 | 0.55 |
RP11-392B6.1 |
|
90089 |
0.09 |
chr20_30743365_30743658 | 0.54 |
ENSG00000265736 |
. |
36957 |
0.11 |
chr2_66735450_66735818 | 0.50 |
MEIS1 |
Meis homeobox 1 |
425 |
0.88 |
chr8_27501056_27501559 | 0.49 |
SCARA3 |
scavenger receptor class A, member 3 |
9609 |
0.16 |
chr3_70882578_70882827 | 0.49 |
ENSG00000206939 |
. |
25201 |
0.23 |
chr2_207972754_207973110 | 0.48 |
ENSG00000253008 |
. |
1865 |
0.35 |
chr8_108208326_108208625 | 0.46 |
ENSG00000211995 |
. |
58251 |
0.16 |
chr12_26811451_26811602 | 0.46 |
RP11-666F17.1 |
|
35224 |
0.22 |
chr14_100240950_100241315 | 0.45 |
EML1 |
echinoderm microtubule associated protein like 1 |
1091 |
0.59 |
chr12_109060942_109061130 | 0.44 |
ENSG00000238457 |
. |
1188 |
0.4 |
chr6_85293592_85293821 | 0.44 |
RP11-132M7.3 |
|
105437 |
0.08 |
chr6_37669094_37669483 | 0.42 |
MDGA1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
2206 |
0.4 |
chr9_107630817_107631231 | 0.41 |
RP11-217B7.2 |
|
58810 |
0.12 |
chr2_36720605_36720756 | 0.41 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
20153 |
0.19 |
chr8_145562069_145562399 | 0.41 |
SCRT1 |
scratch family zinc finger 1 |
2291 |
0.12 |
chr17_26498050_26498459 | 0.41 |
PYY2 |
peptide YY, 2 (pseudogene) |
56078 |
0.09 |
chr6_39787204_39787470 | 0.40 |
DAAM2 |
dishevelled associated activator of morphogenesis 2 |
26543 |
0.21 |
chr7_41910301_41910559 | 0.40 |
AC005027.3 |
|
165497 |
0.04 |
chr17_66379311_66379462 | 0.39 |
ENSG00000207561 |
. |
41303 |
0.14 |
chr8_116430587_116430872 | 0.39 |
TRPS1 |
trichorhinophalangeal syndrome I |
73719 |
0.12 |
chr4_7649546_7649747 | 0.39 |
SORCS2 |
sortilin-related VPS10 domain containing receptor 2 |
86361 |
0.09 |
chr9_94154220_94154371 | 0.39 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
30100 |
0.21 |
chr3_188692042_188692831 | 0.38 |
TPRG1 |
tumor protein p63 regulated 1 |
27433 |
0.27 |
chr17_13316675_13316828 | 0.38 |
ENSG00000266115 |
. |
86894 |
0.1 |
chr4_167261736_167261962 | 0.37 |
ENSG00000206711 |
. |
27663 |
0.26 |
chr1_32123952_32124158 | 0.37 |
RP11-73M7.6 |
|
1196 |
0.35 |
chrX_39586002_39586188 | 0.36 |
ENSG00000264618 |
. |
59982 |
0.14 |
chr10_20884985_20885136 | 0.36 |
ENSG00000265372 |
. |
44161 |
0.21 |
chr1_118238359_118238510 | 0.36 |
ENSG00000212266 |
. |
7070 |
0.28 |
chr9_90131509_90131738 | 0.35 |
DAPK1 |
death-associated protein kinase 1 |
17703 |
0.23 |
chr2_38054791_38055066 | 0.35 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
89317 |
0.09 |
chr3_171978629_171978920 | 0.35 |
ENSG00000243398 |
. |
23658 |
0.19 |
chr12_56917827_56917978 | 0.35 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
2119 |
0.23 |
chr3_129311849_129312381 | 0.35 |
ENSG00000239437 |
. |
1923 |
0.28 |
chr2_80220201_80220486 | 0.34 |
AC016716.2 |
|
37334 |
0.22 |
chr8_86971952_86972334 | 0.34 |
ATP6V0D2 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 |
27409 |
0.23 |
chr14_77873001_77873391 | 0.34 |
FKSG61 |
|
9545 |
0.11 |
chr13_108486642_108486793 | 0.34 |
FAM155A-IT1 |
FAM155A intronic transcript 1 (non-protein coding) |
1082 |
0.62 |
chr12_118770370_118770546 | 0.34 |
TAOK3 |
TAO kinase 3 |
26452 |
0.21 |
chr11_118393531_118393828 | 0.34 |
TTC36 |
tetratricopeptide repeat domain 36 |
4508 |
0.12 |
chr14_24837858_24838637 | 0.34 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
41 |
0.94 |
chr21_39659541_39659821 | 0.33 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
8798 |
0.29 |
chr4_57597998_57598267 | 0.33 |
HOPX |
HOP homeobox |
50067 |
0.12 |
chr7_75952019_75952170 | 0.33 |
HSPB1 |
heat shock 27kDa protein 1 |
19200 |
0.14 |
chr13_27597624_27597775 | 0.33 |
USP12-AS1 |
USP12 antisense RNA 1 |
139293 |
0.04 |
chr3_71030532_71030802 | 0.33 |
FOXP1 |
forkhead box P1 |
83410 |
0.1 |
chr1_149743371_149743522 | 0.33 |
FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
10781 |
0.09 |
chr7_130904360_130904511 | 0.33 |
MKLN1 |
muskelin 1, intracellular mediator containing kelch motifs |
65386 |
0.12 |
chr21_40856650_40856801 | 0.33 |
SH3BGR |
SH3 domain binding glutamic acid-rich protein |
15024 |
0.18 |
chr13_101539869_101540020 | 0.33 |
NALCN-AS1 |
NALCN antisense RNA 1 |
179365 |
0.03 |
chr15_85548703_85549030 | 0.33 |
PDE8A |
phosphodiesterase 8A |
23654 |
0.18 |
chr10_94756810_94756961 | 0.32 |
EXOC6 |
exocyst complex component 6 |
346 |
0.91 |
chr20_19478003_19478154 | 0.32 |
ENSG00000216017 |
. |
92753 |
0.08 |
chr2_200604102_200604338 | 0.32 |
FTCDNL1 |
formiminotransferase cyclodeaminase N-terminal like |
111376 |
0.07 |
chr10_79021361_79021706 | 0.31 |
RP11-328K22.1 |
|
52166 |
0.15 |
chr8_11319032_11319411 | 0.31 |
FAM167A |
family with sequence similarity 167, member A |
5055 |
0.17 |
chr3_12632091_12632446 | 0.31 |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
18477 |
0.14 |
chr10_17217462_17217735 | 0.31 |
TRDMT1 |
tRNA aspartic acid methyltransferase 1 |
939 |
0.58 |
chr11_20111347_20111612 | 0.31 |
NAV2-AS1 |
NAV2 antisense RNA 1 |
30699 |
0.17 |
chr8_20125798_20125949 | 0.31 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
13070 |
0.19 |
chr4_89647157_89647308 | 0.31 |
FAM13A-AS1 |
FAM13A antisense RNA 1 |
4366 |
0.21 |
chr1_208250614_208250765 | 0.31 |
CD34 |
CD34 molecule |
165942 |
0.04 |
chr9_112955106_112955494 | 0.31 |
C9orf152 |
chromosome 9 open reading frame 152 |
15169 |
0.23 |
chr5_15249746_15249921 | 0.31 |
ENSG00000202269 |
. |
138804 |
0.05 |
chr14_77238822_77239041 | 0.31 |
VASH1 |
vasohibin 1 |
5418 |
0.19 |
chr10_30831887_30832121 | 0.31 |
ENSG00000239744 |
. |
12829 |
0.24 |
chr10_70089432_70089583 | 0.31 |
HNRNPH3 |
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
2325 |
0.26 |
chr1_201706190_201706778 | 0.31 |
RP11-90L20.2 |
|
150 |
0.93 |
chr15_57574971_57575503 | 0.31 |
TCF12 |
transcription factor 12 |
584 |
0.78 |
chr18_32694549_32694734 | 0.30 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
73027 |
0.11 |
chr18_54126758_54127059 | 0.30 |
TXNL1 |
thioredoxin-like 1 |
154814 |
0.04 |
chr4_122569979_122570130 | 0.30 |
ANXA5 |
annexin A5 |
48063 |
0.16 |
chr3_105699405_105699556 | 0.30 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
111084 |
0.08 |
chr9_81321983_81322311 | 0.30 |
PSAT1 |
phosphoserine aminotransferase 1 |
410088 |
0.01 |
chr11_14562787_14563173 | 0.30 |
PSMA1 |
proteasome (prosome, macropain) subunit, alpha type, 1 |
20738 |
0.2 |
chr11_126084700_126085013 | 0.30 |
ENSG00000222067 |
. |
483 |
0.66 |
chr7_80348902_80349053 | 0.30 |
CD36 |
CD36 molecule (thrombospondin receptor) |
46285 |
0.2 |
chr11_16377737_16377888 | 0.30 |
SOX6 |
SRY (sex determining region Y)-box 6 |
14997 |
0.3 |
chr8_91795476_91795627 | 0.30 |
NECAB1 |
N-terminal EF-hand calcium binding protein 1 |
8227 |
0.21 |
chr2_158326449_158327167 | 0.29 |
CYTIP |
cytohesin 1 interacting protein |
18533 |
0.22 |
chr12_66270554_66270788 | 0.29 |
RP11-366L20.2 |
Uncharacterized protein |
4687 |
0.21 |
chr6_14638853_14639371 | 0.29 |
ENSG00000206960 |
. |
7654 |
0.34 |
chr9_125766060_125766211 | 0.29 |
RABGAP1 |
RAB GTPase activating protein 1 |
29653 |
0.12 |
chr11_131479604_131479755 | 0.29 |
NTM |
neurotrimin |
27774 |
0.2 |
chr1_100976278_100976464 | 0.29 |
RP5-837M10.4 |
|
24818 |
0.19 |
chr7_16568149_16568300 | 0.29 |
LRRC72 |
leucine rich repeat containing 72 |
1703 |
0.34 |
chr12_1727335_1727720 | 0.29 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
1305 |
0.46 |
chr3_72036989_72037274 | 0.29 |
ENSG00000239250 |
. |
160803 |
0.04 |
chr17_29925275_29925666 | 0.29 |
ENSG00000199187 |
. |
23040 |
0.11 |
chr12_71040223_71040434 | 0.29 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
9108 |
0.29 |
chr5_123171717_123171868 | 0.29 |
CSNK1G3 |
casein kinase 1, gamma 3 |
247673 |
0.02 |
chr4_187545719_187545870 | 0.29 |
FAT1 |
FAT atypical cadherin 1 |
26616 |
0.2 |
chr6_22821870_22822021 | 0.29 |
HDGFL1 |
hepatoma derived growth factor-like 1 |
252150 |
0.02 |
chr18_5516139_5516334 | 0.29 |
EPB41L3 |
erythrocyte membrane protein band 4.1-like 3 |
5186 |
0.21 |
chr8_80226395_80226546 | 0.29 |
ENSG00000264969 |
. |
216872 |
0.02 |
chr7_92382094_92382391 | 0.28 |
ENSG00000206763 |
. |
51114 |
0.14 |
chr3_99672505_99672656 | 0.28 |
ENSG00000264897 |
. |
10662 |
0.27 |
chr5_17282736_17283060 | 0.28 |
ENSG00000252908 |
. |
42178 |
0.15 |
chr2_36680268_36680419 | 0.28 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
60490 |
0.12 |
chr3_43827332_43827483 | 0.28 |
ABHD5 |
abhydrolase domain containing 5 |
74208 |
0.11 |
chr1_221187846_221187997 | 0.28 |
HLX |
H2.0-like homeobox |
133337 |
0.05 |
chr15_67006142_67006408 | 0.28 |
SMAD6 |
SMAD family member 6 |
2240 |
0.39 |
chr19_5955434_5955585 | 0.28 |
RANBP3 |
RAN binding protein 3 |
22581 |
0.09 |
chr12_24383050_24383201 | 0.28 |
ENSG00000216192 |
. |
17770 |
0.3 |
chr20_56050830_56050981 | 0.28 |
CTCFL |
CCCTC-binding factor (zinc finger protein)-like |
48408 |
0.12 |
chr5_146917975_146918126 | 0.28 |
DPYSL3 |
dihydropyrimidinase-like 3 |
28431 |
0.24 |
chr11_112036083_112036234 | 0.28 |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
1318 |
0.25 |
chr1_200332138_200332309 | 0.28 |
ZNF281 |
zinc finger protein 281 |
46897 |
0.19 |
chr2_98708440_98708797 | 0.28 |
VWA3B |
von Willebrand factor A domain containing 3B |
4919 |
0.31 |
chr18_65188248_65188399 | 0.27 |
DSEL |
dermatan sulfate epimerase-like |
4106 |
0.29 |
chr11_103924198_103924349 | 0.27 |
PDGFD |
platelet derived growth factor D |
16519 |
0.22 |
chr17_30586530_30586681 | 0.27 |
RHBDL3 |
rhomboid, veinlet-like 3 (Drosophila) |
6590 |
0.16 |
chr2_98546607_98546758 | 0.27 |
ENSG00000238719 |
. |
17102 |
0.21 |
chr7_77130046_77130330 | 0.27 |
PTPN12 |
protein tyrosine phosphatase, non-receptor type 12 |
36404 |
0.19 |
chr18_60117683_60118024 | 0.27 |
ZCCHC2 |
zinc finger, CCHC domain containing 2 |
72387 |
0.1 |
chr12_26171601_26171752 | 0.27 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
2697 |
0.33 |
chr11_63278500_63278680 | 0.27 |
LGALS12 |
lectin, galactoside-binding, soluble, 12 |
3131 |
0.21 |
chr20_43176865_43177016 | 0.27 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
16370 |
0.14 |
chr10_6390281_6390901 | 0.27 |
DKFZP667F0711 |
|
1687 |
0.47 |
chr15_50392799_50393114 | 0.27 |
ATP8B4 |
ATPase, class I, type 8B, member 4 |
13745 |
0.23 |
chr9_5450626_5450802 | 0.27 |
CD274 |
CD274 molecule |
189 |
0.95 |
chr11_34338329_34338672 | 0.27 |
ABTB2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
40302 |
0.19 |
chr5_153350030_153350181 | 0.27 |
FAM114A2 |
family with sequence similarity 114, member A2 |
66765 |
0.12 |
chr6_144126645_144127098 | 0.27 |
LTV1 |
LTV1 homolog (S. cerevisiae) |
37610 |
0.18 |
chr6_82477389_82477689 | 0.27 |
ENSG00000206886 |
. |
3798 |
0.25 |
chr7_91513061_91513319 | 0.27 |
MTERF |
mitochondrial transcription termination factor |
3156 |
0.35 |
chr1_149358385_149358581 | 0.27 |
FCGR1C |
Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene |
10811 |
0.14 |
chr10_80893653_80893925 | 0.27 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
64997 |
0.13 |
chr2_145270130_145270606 | 0.27 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
4747 |
0.27 |
chr21_37360811_37360962 | 0.27 |
RUNX1 |
runt-related transcription factor 1 |
16079 |
0.16 |
chr9_8718077_8718278 | 0.27 |
PTPRD |
protein tyrosine phosphatase, receptor type, D |
15717 |
0.22 |
chr11_61467806_61468091 | 0.27 |
DAGLA |
diacylglycerol lipase, alpha |
20043 |
0.15 |
chr3_16005968_16006176 | 0.27 |
ENSG00000207815 |
. |
90794 |
0.08 |
chr8_72770819_72770970 | 0.27 |
MSC |
musculin |
14191 |
0.18 |
chr6_82476723_82477129 | 0.26 |
ENSG00000206886 |
. |
3185 |
0.27 |
chr8_105598551_105598718 | 0.26 |
LRP12 |
low density lipoprotein receptor-related protein 12 |
2600 |
0.3 |
chr3_151122388_151122772 | 0.26 |
P2RY12 |
purinergic receptor P2Y, G-protein coupled, 12 |
19980 |
0.18 |
chr3_71297288_71297645 | 0.26 |
FOXP1 |
forkhead box P1 |
3150 |
0.35 |
chr6_70294956_70295144 | 0.26 |
ENSG00000265362 |
. |
36215 |
0.23 |
chr12_124474900_124475063 | 0.26 |
ZNF664 |
zinc finger protein 664 |
17139 |
0.08 |
chr4_141058656_141058807 | 0.26 |
RP11-392B6.1 |
|
9562 |
0.23 |
chr12_109003340_109003491 | 0.26 |
TMEM119 |
transmembrane protein 119 |
11319 |
0.13 |
chr3_114951923_114952074 | 0.26 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
85880 |
0.11 |
chr8_41786362_41786614 | 0.26 |
KAT6A |
K(lysine) acetyltransferase 6A |
29393 |
0.17 |
chr13_47317430_47317715 | 0.26 |
ESD |
esterase D |
38131 |
0.19 |
chr1_222507571_222507774 | 0.26 |
ENSG00000222399 |
. |
169405 |
0.03 |
chr1_209465302_209465601 | 0.26 |
ENSG00000230937 |
. |
140027 |
0.05 |
chr4_120580539_120580789 | 0.26 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
30518 |
0.22 |
chr12_19805873_19806024 | 0.26 |
ENSG00000200885 |
. |
71421 |
0.13 |
chr3_124869997_124870148 | 0.26 |
ENSG00000264986 |
. |
324 |
0.89 |
chr11_67886734_67886961 | 0.26 |
CHKA |
choline kinase alpha |
1448 |
0.32 |
chr14_72179521_72179805 | 0.26 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
94190 |
0.09 |
chr3_72059056_72059299 | 0.26 |
ENSG00000239250 |
. |
182849 |
0.03 |
chr11_34438827_34438978 | 0.26 |
CAT |
catalase |
21570 |
0.21 |
chr3_18585987_18586243 | 0.25 |
ENSG00000228956 |
. |
17451 |
0.28 |
chr10_115033205_115033385 | 0.25 |
ENSG00000238380 |
. |
79889 |
0.11 |
chr18_9704973_9705544 | 0.25 |
RAB31 |
RAB31, member RAS oncogene family |
2904 |
0.31 |
chr4_52798315_52798466 | 0.25 |
DCUN1D4 |
DCN1, defective in cullin neddylation 1, domain containing 4 |
40417 |
0.19 |
chr1_178102702_178103151 | 0.25 |
RASAL2 |
RAS protein activator like 2 |
39650 |
0.22 |
chr6_154808814_154808965 | 0.25 |
CNKSR3 |
CNKSR family member 3 |
9264 |
0.31 |
chr14_75428743_75429108 | 0.25 |
PGF |
placental growth factor |
6438 |
0.15 |
chr18_10269165_10269316 | 0.25 |
ENSG00000239031 |
. |
120757 |
0.06 |
chr16_85295971_85296292 | 0.25 |
ENSG00000266307 |
. |
43800 |
0.16 |
chr10_62109936_62110087 | 0.25 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
39477 |
0.23 |
chr9_4927697_4927848 | 0.25 |
ENSG00000238362 |
. |
40325 |
0.13 |
chr12_57620818_57620969 | 0.25 |
ENSG00000202067 |
. |
864 |
0.38 |
chr2_58926103_58926452 | 0.25 |
FANCL |
Fanconi anemia, complementation group L |
457770 |
0.01 |
chr1_64208231_64208526 | 0.25 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
31315 |
0.2 |
chr7_40803485_40803636 | 0.25 |
AC005160.3 |
|
11597 |
0.32 |
chr20_43330295_43330446 | 0.25 |
RP11-445H22.3 |
|
5633 |
0.14 |
chr5_176901771_176902224 | 0.25 |
DBN1 |
drebrin 1 |
595 |
0.56 |
chr9_95298761_95298917 | 0.25 |
ECM2 |
extracellular matrix protein 2, female organ and adipocyte specific |
98 |
0.97 |
chr5_67829635_67829905 | 0.25 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
241374 |
0.02 |
chr10_17064484_17064884 | 0.25 |
CUBN |
cubilin (intrinsic factor-cobalamin receptor) |
38490 |
0.2 |
chr1_35309309_35309515 | 0.25 |
RP5-997D16.2 |
|
6883 |
0.15 |
chr13_41639811_41639962 | 0.25 |
WBP4 |
WW domain binding protein 4 |
4190 |
0.18 |
chr10_73000505_73000775 | 0.25 |
UNC5B-AS1 |
UNC5B antisense RNA 1 |
22655 |
0.16 |
chr10_102813488_102813726 | 0.25 |
KAZALD1 |
Kazal-type serine peptidase inhibitor domain 1 |
7991 |
0.12 |
chr6_148845405_148845556 | 0.24 |
ENSG00000223322 |
. |
104 |
0.98 |
chr7_141061897_141062048 | 0.24 |
RP5-842K16.2 |
|
69096 |
0.12 |
chr6_135740137_135740472 | 0.24 |
AHI1 |
Abelson helper integration site 1 |
7658 |
0.26 |
chr1_221096418_221096569 | 0.24 |
HLX |
H2.0-like homeobox |
41909 |
0.16 |
chr4_169536059_169536210 | 0.24 |
PALLD |
palladin, cytoskeletal associated protein |
16632 |
0.21 |
chr17_67925463_67925614 | 0.24 |
ENSG00000252100 |
. |
19550 |
0.24 |
chr3_155926514_155926665 | 0.24 |
KCNAB1-AS2 |
KCNAB1 antisense RNA 2 |
19083 |
0.25 |
chr5_58473985_58474185 | 0.24 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
97860 |
0.09 |
chr15_71824033_71824261 | 0.24 |
THSD4 |
thrombospondin, type I, domain containing 4 |
15428 |
0.25 |
chr3_81913343_81913495 | 0.24 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
102107 |
0.09 |
chr12_20000530_20000725 | 0.24 |
ENSG00000200885 |
. |
123258 |
0.06 |
chr13_77319833_77320172 | 0.24 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
140523 |
0.05 |
chr19_39157057_39157758 | 0.24 |
ACTN4 |
actinin, alpha 4 |
19029 |
0.11 |
chr2_36780540_36780944 | 0.24 |
AC007401.2 |
Uncharacterized protein |
1331 |
0.45 |
chrX_124435894_124436045 | 0.24 |
ENSG00000263886 |
. |
14344 |
0.31 |
chr11_69264697_69264848 | 0.24 |
CCND1 |
cyclin D1 |
191083 |
0.03 |
chr1_213499715_213500068 | 0.24 |
RPS6KC1 |
ribosomal protein S6 kinase, 52kDa, polypeptide 1 |
275287 |
0.01 |
chr20_50419228_50419379 | 0.24 |
SALL4 |
spalt-like transcription factor 4 |
244 |
0.94 |
chr5_124202510_124202693 | 0.24 |
ZNF608 |
zinc finger protein 608 |
118101 |
0.05 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.3 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0021508 | floor plate formation(GO:0021508) |
0.0 | 0.1 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.0 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.2 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.2 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0048342 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.1 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.0 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.0 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |